Literature DB >> 9225373

Free-running circadian rhythm of melatonin in a sighted man despite a 24-hour sleep pattern: a non-24-hour circadian syndrome.

S Hashimoto1, K Nakamura, S Honma, K Honma.   

Abstract

Sleep and plasma melatonin rhythms were measured longitudinally in a sighted young man (21 years old) under a day-right environment. At each measurement, the responsiveness of the melatonin rhythm to a single light pulse was examined in addition to the 24-hour profile. In experiment 1, the timing of sleep was decided by the subject himself. Although most sleep episodes were observed between 21:02 h and 10:55 h, the plasma melatonin rhythm free-ran for a period of 24.18 h. In experiment 2, the sleep-wake schedule of the subject was strictly fixed. The subject was instructed to go do bed at 24:00 h and wake up, at the latest, before 8:00 h for 40 days. The melatonin rhythm, however, continued to free-run for a period of 24.12 h. Nocturnal melatonin level could not be suppressed by a 3-hour light pulse of 500 lx, but was suppressed by a pulse of 1000 lx. It is concluded that internal desynchronization occurred in this particular sighted subject where the sleep-wake rhythm was entrained by the 24-hour day-night environment, whereas the plasma melatonin rhythm free ran, and that a forced sleep schedule did not act as a strong zeitgeber.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225373     DOI: 10.1111/j.1440-1819.1997.tb02371.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  3 in total

1.  Circadian Rhythm Sleep Disorders.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

2.  Therapeutics for Circadian Rhythm Sleep Disorders.

Authors:  Ehren R Dodson; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2010-12

3.  Melatonin in Epilepsy: A New Mathematical Model of Diurnal Secretion.

Authors:  Justyna Paprocka; Marek Kijonka; Marcin Pęcka; Maria Sokół
Journal:  Int J Endocrinol       Date:  2016-07-13       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.